Memphasys (ASX:MEM) has signed a five-year commercial supply agreement with Centro Fertilita Assistita Italia, one of Italy's largest private IVF groups based in Naples.
The agreement, valued at a minimum of €525,000, includes the purchase of 3,000 Felix cartridges in the first two years and 1,500 cartridges annually thereafter, totaling 7,500 cartridges over the contract term.
Ahead of CE Mark approval, CFA Italia has placed an initial order for 500 Felix cartridges with revenue recognised this quarter and cash expected next quarter.
This early order reflects strong clinical demand generated through Memphasys' direct commercialisation model, following on-site training and clinical onboarding.
The deal marks Memphasys' first commercial contract in mainland Europe, expanding its footprint alongside agreements in Japan, India, and the Middle East.